All patients
Age < 65y (younger) Age > 65y Asian type ECOG 0 ECOG 1 EGFR mutant Gender, female Gender, male metastasis (brain) NO metastasis (brain) YES metastasis (liver ) PD-L1 < 1% PD-L1 > 1% PDL1 (TC0 and IC0 : <1% of TC and IC) PDL1 (TC1/2 or IC1/2 : ≥1% of TC or IC and <50% of TC and <10% of IC) PDL1 (TC1/2/3 or IC1/2/3 : ≥1% of TC or IC) PDL1 (TC3 or IC3 : ≥50% of TC or ≥10% of IC ) PDL1 (TPS >50%) smoker (current or former) smoker (Current) smoker (never)
Top evidence (RCT only, high risk of bias excluded)
Best available evidence (possibly low or very low)
All RCTs
All studies (RCT+OBS)
studies
non squamous - mNSCLC - L1 - Wild Type (WT), immune chekpoint inhibitors vs. carboplatin plus nab-paclitaxel, meta-analysis of study results Outcome TE 95% CI n k I2 ROB Pub. bias deaths (OS)detailed results IMpower-130 (WT), 2019 0.79 [0.64; 0.98]
0.79 [0.64 ; 0.98 ] IMpower-130 (WT), 2019 1 0% 679 NA not evaluable progression or deaths (PFS)detailed results IMpower-130 (WT), 2019 0.64 [0.54; 0.76]
0.64 [0.54 ; 0.76 ] IMpower-130 (WT), 2019 1 0% 679 NA not evaluable DORdetailed results IMpower-130 (WT), 2019 2.41 [1.27; 4.60]
2.41 [1.27 ; 4.60 ] IMpower-130 (WT), 2019 1 0% 292 NA not evaluable objective responses (ORR)detailed results IMpower-130 (WT), 2019 2.07 [1.48; 2.89]
2.07 [1.48 ; 2.89 ] IMpower-130 (WT), 2019 1 0% 673 NA not evaluable 0.2 5.0 1.0 relative treatment effect www.metaEvidence.org 2024-10-06 02:13 +02:00
TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers);
k: number of studies; n: total number of patients;
ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1;
studied treatment is better when TE < 1;
pathologies: 176
- treatments: 204,504,850,329,558,579,549,868,502,741,556,812,813,367,851,361,602,1070,671,865,744,696,1083,1281,1282,1283,1082,866,852,417,603,1051,876,853,1018,661,673,1049,1440,1561,854,374,953,672,1080,1560,1073,862,1562,1565,855,360,719,721,720,842,642,674,1085,863,503,847,982,359,575,577,576,869,1081,981,875,505,952,1021,1079,767,1071,1074,873,561,644,1251,1044,724,874,1043,1041,1042,940,1258,1563,746,745,856,634,861,416,864,769,980,369,743